Clinical trials
Completed Ocular Hypertension trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 5 |
| 2011 | 1 |
| 2015 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Allergan | 6 |
| Alcon Research | 2 |
| Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong | 1 |
| Nicox Ophthalmics, Inc. | 1 |
| Otsuka Beijing Research Institute | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
| Santen Pharmaceutical Co., Ltd. | 1 |
| Visionary Intelligence Ltd. | 1 |
| Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ocular Hypertension | 15 |
| Glaucoma, Open-Angle | 12 |
| Glaucoma | 4 |
| Central Serous Chorioretinopathy | 1 |
| Diabetic Retinopathy | 1 |
| Epiretinal Membrane | 1 |
| Glaucoma, Angle-Closure | 1 |
| Optic Atrophy | 1 |
| Retinal Artery Occlusion | 1 |
| Retinal Detachment | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.